State Street’s Histogen Inc. Common Stock HSTO Stock Holding History

State Street’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,610	Closed	-$43K	–	5013
2022 Q1	$43K	Hold	8,610	–	–	﹤0.01%	4822
2021 Q4	$57K	Hold	8,610	–	–	﹤0.01%	4680
2021 Q3	$130K	Hold	8,610	–	–	﹤0.01%	4484
2021 Q2	$188K	Buy	+8,610	New	+$179K	﹤0.01%	4232
2020 Q2	–	Sell	-83	Closed	-$5K	–	3875
2020 Q1	$5K	Hold	83	–	–	﹤0.01%	3748
2019 Q4	$7K	Hold	83	–	–	﹤0.01%	3794
2019 Q3	$5K	Hold	83	–	–	﹤0.01%	3800
2019 Q2	$4K	Sell	83 -104	-56%	-$18K	﹤0.01%	3811
2019 Q1	$40K	Sell	187 -4	-2%	-$1.61K	﹤0.01%	3687
2018 Q4	$66K	Sell	191 -4	-2%	-$3.11K	﹤0.01%	3664
2018 Q3	$226K	Buy	195 +8	+4%	+$7.37K	﹤0.01%	3584
2018 Q2	$161K	Sell	187 -1,872	-91%	-$1.55M	﹤0.01%	3587
2018 Q1	$2.42M	Buy	2,059 +47	+2%	+$52K	﹤0.01%	3091
2017 Q4	$1.86M	Buy	2,012 +151	+8%	+$139K	﹤0.01%	3212
2017 Q3	$2.04M	Buy	1,861 +47	+3%	+$53.5K	﹤0.01%	3196
2017 Q2	$2.09M	Buy	+1,814	New	+$2.21M	﹤0.01%	3114
2014 Q2	–	Sell	-230	Closed	-$373K	–	3686
2014 Q1	$373K	Buy	230 +9	+4%	+$18.8K	﹤0.01%	3392
2013 Q4	$286K	Buy	221 +31	+16%	+$49.5K	﹤0.01%	3415
2013 Q3	$381K	Buy	+190	New	+$353K	﹤0.01%	3377

Other funds holding HSTO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street's HSTO Position: Q2 2022 in Review

State Street sold out of Histogen Inc. Common Stock (HSTO) in Q2 2022, closing a stake of 8,610 shares — an estimated $43K sold.

State Street first reported a position in HSTO in Q3 2013 and held it in 19 quarters. The position peaked at $2.42M in Q1 2018. 10 funds tracked by Wall St. Rank hold HSTO as of Q2 2022.

State Street reported no remaining Histogen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
State Street sold 8,610 Histogen Inc. Common Stock shares in Q2 2022, an estimated $43K.
State Street first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 19 quarters.
State Street's Histogen Inc. Common Stock position peaked at $2.42M in Q1 2018.
10 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.